Drugs that contain Brincidofovir

1. Drug name - TEMBEXA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9303051 CHIMERIX Phosphonate ester derivatives and methods of synthesis thereof
Aug, 2031

(8 years from now)

US8962829 CHIMERIX Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof
Oct, 2034

(12 years from now)

CN105998039A CHIMERIX Phosphonate Ester Derivatives And Synthesis Method Thereof
Jun, 2019

(3 years ago)

CN105218580A CHIMERIX Phosphonate Ester Derivatives And Methods Of Synthesis Thereof
May, 2021

(1 year, 4 months ago)

CN103209985B CHIMERIX Phosphonate Derivative And Synthesis Method Thereof
Aug, 2031

(8 years from now)

CN103209985A CHIMERIX Phosphonate Ester Derivatives And Methods Of Synthesis Thereof
Aug, 2031

(8 years from now)

IN201627019468A CHIMERIX Morphic Forms Of Hexadecyloxypropyl Phosphonate Esters
Oct, 2034

(12 years from now)

IN328711B CHIMERIX A Method Of Preperation Of Morphic Forms Of Hexadecyloxyprop Yl-Phosphonate Esters
Oct, 2034

(12 years from now)

EP2611818A2 CHIMERIX Phosphonate Ester Derivatives And Methods Of Synthesis Thereof
Aug, 2031

(8 years from now)

EP2611818A4 CHIMERIX Phosphonate Ester Derivatives And Methods Of Synthesis Thereof
Aug, 2031

(8 years from now)

EP3020720A1 CHIMERIX Phosphonate Ester Derivatives And Methods Of Synthesis Thereof
Aug, 2031

(8 years from now)

EP2611818B1 CHIMERIX Phosphonate Ester Derivatives And Methods Of Synthesis Thereof
Aug, 2031

(8 years from now)

EP3020720B1 CHIMERIX Phosphonate Ester Derivatives And Methods Of Synthesis Thereof
Aug, 2031

(8 years from now)

EP2999476B1 CHIMERIX Morphic Forms Of Hexadecyloxypropyl-Phosphonate Esters
Oct, 2034

(12 years from now)

EP2999476A1 CHIMERIX Morphic Forms Of Hexadecyloxypropyl-Phosphonate Esters
Oct, 2034

(12 years from now)

EP2999476A4 CHIMERIX Morphic Forms Of Hexadecyloxypropyl-Phosphonate Esters
Oct, 2034

(12 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10112909 CHIMERIX Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Oct, 2034

(12 years from now)

US10487061 CHIMERIX Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Oct, 2034

(12 years from now)

US9371344 CHIMERIX Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Oct, 2034

(12 years from now)

Treatment: Method of treating human smallpox disease

Dosage: SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
10MG/ML SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.